Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.

导出原文传递

翻译打印收藏纠错

作者： Sandra,Iurescia ^[1] ; Daniela,Fioretti ^[1] ; Monica,Rinaldi ^[1]

作者单位： Institute of Translational Pharmacology (IFT), Department of Biomedical Sciences, National Research Council (CNR), via Fosso del Cavaliere 100 - 00133 Rome. Italy. ^[1]

关键词 RIG-I STING cGAMP cGAS cyclic dinucleotides (CDNs)-based adjuvants; immuno-oncology agents innate immunity

主题词动物(Animals);抗肿瘤药(Antineoplastic Agents);临床试验(主题)(Clinical Trials as Topic);人类(Humans);免疫, 先天(Immunity, Innate);免疫疗法(Immunotherapy);肿瘤(Neoplasms);核酸类(Nucleic Acids);专利(主题)(Patents as Topic);肿瘤微环境(Tumor Microenvironment)

DOI 10.2174/1574892812666171030163804

PMID 29086701

发布时间 2018-08-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Recent patents on anti-cancer drug discovery

2018年13卷1期

2-17页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.

Recent patents on anti-cancer drug discovery

相似文献

Recent patents on anti-cancer drug discovery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.

Recent patents on anti-cancer drug discovery

相似文献

Recent patents on anti-cancer drug discovery

相关期刊

检索历史清除